These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7013166)

  • 1. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E
    Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring of phenytoin in critically ill patients.
    von Winckelmann SL; Spriet I; Willems L
    Pharmacotherapy; 2008 Nov; 28(11):1391-400. PubMed ID: 18956999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of free level monitoring of antiepileptic drugs.
    Levy RH; Schmidt D
    Epilepsia; 1985; 26(3):199-205. PubMed ID: 3924585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease.
    Hooper WD; Bochner F; Eadie MJ; Tyrer JH
    Clin Pharmacol Ther; 1974 Mar; 15(3):276-82. PubMed ID: 4815953
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of spin labeling to drug assays. II. Determination of the binding of [14C]-phenytoin and spin-labeled phenytoins to albumin and human serum.
    Chou D; Polnaszek CF; Yost Y; Leppik IE; Holtzman JL
    Mol Pharmacol; 1981 Nov; 20(3):674-80. PubMed ID: 7329409
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the drug-binding defect in plasma from rats with glycerol-induced acute renal failure.
    Bowmer CJ; Lindup WE
    J Pharmacol Exp Ther; 1979 Sep; 210(3):440-5. PubMed ID: 480193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug interactions through influencing plasma-protein binding].
    Ohnhaus EE
    Internist (Berl); 1979 May; 20(5):225-8. PubMed ID: 376478
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and pethidine using equilibrium dialysis and ultracentrifugation.
    Verbeeck RK; Cardinal JA
    Arzneimittelforschung; 1985; 35(6):903-6. PubMed ID: 4026915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A; Sperelakis A; Mason A; Dean R
    Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients.
    Bowdle TA; Neal GD; Levy RH; Heimbach DM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):97-9. PubMed ID: 7359372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-bound and free plasma phenytoin during pregnancy.
    Lecomte M; Albengres E; Huraux-Rendu C; Tillement JP; Gautray JP
    Int J Biol Res Pregnancy; 1981; 2(2):95-8. PubMed ID: 7333696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A; Olsson Y; Sjöholm I
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract]   [Full Text] [Related]  

  • 19. Diphenylhydantoin potency and plasma protein binding.
    Shoeman DW; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Oct; 195(1):84-6. PubMed ID: 1181407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data.
    Battino D; Croci D; Mamoli D; Messina S; Perucca E
    Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.